Yasuhiro Yuasa

Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With <i>RAS</i> Wild-type, Left-Sided Metastatic Colorectal Cancer

Jun Watanabe, Kei Muro, Kohei Shitara et al. · JAMA · 2023 · 222 citations · Full text

Sequential activation of Raf-1 kinase, mitogen-activated protein (MAP) kinase kinase, MAP kinase, and S6 kinase by hyperosmolality in renal cells.

Yoshio Terada, Kimio Tomita, Hiroshi Nonoguchi et al. · Journal of Biological Chemistry · 1994 · 116 citations · Full text

Renal Pathology, Renal Inflammation, Nephrology +23

Sentinel Lymph Node Biopsy Using Intraoperative Indocyanine Green Fluorescence Imaging Navigated with Preoperative CT Lymphography for Superficial Esophageal Cancer

Yasuhiro Yuasa, Junichi Seike, Takahiro Yoshida et al. · Annals of Surgical Oncology · 2011 · 106 citations

Engineering, Esophageal Cancer, Medical Imaging +9

Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer

Kohei Shitara, Kei Muro, Jun Watanabe et al. · Nature Medicine · 2024 · 87 citations · Full text

Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System

Chigusa Morizane, Nozomu Machida, Yoshitaka Honma et al. · JAMA Oncology · 2022 · 85 citations · Full text